128 related articles for article (PubMed ID: 19826133)
41. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
42. Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.
Gini A; Meester RGS; Keshavarz H; Oeffinger KC; Ahmed S; Hodgson DC; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2019 Nov; 111(11):1161-1169. PubMed ID: 30980665
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
[TBL] [Abstract][Full Text] [Related]
44. Comparative effectiveness and cost-effectiveness analysis of a urine metabolomics test vs. alternative colorectal cancer screening strategies.
Barichello S; Deng L; Ismond KP; Loomes DE; Kirwin EM; Wang H; Chang D; Svenson LW; Thanh NX
Int J Colorectal Dis; 2019 Nov; 34(11):1953-1962. PubMed ID: 31673772
[TBL] [Abstract][Full Text] [Related]
45. Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina.
Hassmiller Lich K; Cornejo DA; Mayorga ME; Pignone M; Tangka FK; Richardson LC; Kuo TM; Meyer AM; Hall IJ; Smith JL; Durham TA; Chall SA; Crutchfield TM; Wheeler SB
Prev Chronic Dis; 2017 Feb; 14():E18. PubMed ID: 28231042
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
47. Cost-Effectiveness of Community-to-Clinic Tailored Navigation for Colorectal Cancer Screening in an Underserved Population: Economic Evaluation Alongside a Group-Randomized Trial.
Herman PM; Bucho-Gonzalez J; Menon U; Szalacha LA; Larkey L
Am J Health Promot; 2022 May; 36(4):678-686. PubMed ID: 35081762
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer.
Pil L; Fobelets M; Putman K; Trybou J; Annemans L
Eur J Intern Med; 2016 Jul; 32():72-8. PubMed ID: 27157827
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.
Dougherty MK; Brenner AT; Crockett SD; Gupta S; Wheeler SB; Coker-Schwimmer M; Cubillos L; Malo T; Reuland DS
JAMA Intern Med; 2018 Dec; 178(12):1645-1658. PubMed ID: 30326005
[TBL] [Abstract][Full Text] [Related]
50. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
[TBL] [Abstract][Full Text] [Related]
52. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
54. Role of an Implementation Economics Analysis in Providing the Evidence Base for Increasing Colorectal Cancer Screening.
Subramanian S; Tangka FKL; Hoover S
Prev Chronic Dis; 2020 Jun; 17():E46. PubMed ID: 32584756
[TBL] [Abstract][Full Text] [Related]
55. Knowledge, attitude, and practices of primary health care physicians toward colorectal cancer screening.
Mosli M; Alnahdi Y; Alghamdi A; Baabdullah M; Hadadi A; Khateery K; Alsulami I; AlHoqail A; Almadi M; Jawa H; Aljahdli E; Bazarah S; Qari Y
Saudi J Gastroenterol; 2017; 23(6):330-336. PubMed ID: 29205185
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.
Jahn B; Sroczynski G; Bundo M; Mühlberger N; Puntscher S; Todorovic J; Rochau U; Oberaigner W; Koffijberg H; Fischer T; Schiller-Fruehwirth I; Öfner D; Renner F; Jonas M; Hackl M; Ferlitsch M; Siebert U;
BMC Gastroenterol; 2019 Dec; 19(1):209. PubMed ID: 31805871
[TBL] [Abstract][Full Text] [Related]
57. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
[No Abstract] [Full Text] [Related]
58. Increasing colorectal cancer screening orders using unlicensed assistive personnel.
Ishida K; Weiss E; Kee SA; Yingling CT
BMJ Open Qual; 2019; 8(2):e000545. PubMed ID: 31321316
[TBL] [Abstract][Full Text] [Related]
59. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Berger BM; Schroy PC; Dinh TA
Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
